Firm Warned On Spiked Supplements After Closing Door To FDA Official
This article was originally published in The Tan Sheet
Executive Summary
FDA reminds Nova Products of its obligation to allow access to agency inspectors in a warning letter that also notes the firm’s products are unapproved new drugs due to the presence of sildenafil and tadalafil and are misbranded because labeling fails to bear adequate directions for the ingredients’ intended use.